Juliana de Saldanha da Gama Fischer Carvalho

Dr. Juliana de Saldanha da Gama Fischer Carvalho

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2023 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
MCMilan A. Clasen
Milan A. Clasen
MSMarlon Dias Mariano dos Santos
Marlon Dias Mariano dos Santos
LKLouise Ulrich Kurt
Louise Ulrich Kurt
JCJuliana de Saldanha da Gama Fischer Carvalho
Juliana de Saldanha da Gama Fischer Carvalho
ACAmanda C. Camillo-Andrade
Amanda C. Camillo-Andrade
PCPaulo Carvalho
Paulo Carvalho

22 August 2016 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
PAPriscila F. de Aquino
Priscila F. de Aquino
PCPaulo Costa Carvalho
Paulo Costa Carvalho
FNFábio Nogueira
Fábio Nogueira
CFClovis Orlando da Fonseca
Clovis Orlando da Fonseca
JSJúlio Cesar Thomé de Souza Silva
Júlio Cesar Thomé de Souza Silva
JCJuliana de Saldanha da Gama Fischer Carvalho
Juliana de Saldanha da Gama Fischer Carvalho
Tumors consist of cells in different stages of transformation with molecular and cellular heterogeneity. By far, heterogeneity is the hallmark of glioblastoma multiforme (GBM), the most malignant and aggressive type of glioma. Most proteomic studies aim in comparing tumors from different patients, but here we dive into exploring the intratumoral proteome diversity of a single GBM. For this, we profiled tumor fragments from the profound region of the same patient’s GBM but obtained from two surgeries a year’s time apart. Our analysis also included GBM‘s fragments from different anatomical regions. Our quantitative proteomic strategy employed 4-plex iTRAQ peptide labeling followed by a four-step strong cation chromatographic separation; each fraction was then analyzed by reversed-phase nano-chromatography coupled on-line with an Orbitrap-Velos mass spectrometer. Unsupervised clustering grouped the proteomic profiles into four major distinct groups and showed that most changes were related to the tumor’s anatomical region. Our analysis revealed that most changes are related to the tumor’s anatomical region. Nevertheless, we report differentially abundant proteins from GBM’s fragments of the same region but obtained one year apart. We discuss several key proteins (e.g., S100A9) and enriched pathways linked with GBM such as the Ras pathway, RHO GTPases activate PKNs, and those related to apoptosis, to name a few. As far as we know, this is the only report that compares GBM fragments proteomic profiles from the same patient. Ultimately, our results fuel the forefront of scientific discussion on the importance in exploring the richness of subproteomes within a single tissue sample for a better understanding of the disease, as each tumor is unique.

Verified
Journal Article
Open access
PDF file
ESEsdras Matheus Gomes da Silva
Esdras Matheus Gomes da Silva
JCJuliana de Saldanha da Gama Fischer Carvalho
Juliana de Saldanha da Gama Fischer Carvalho
ISIsadora de Lourdes Signorini Souza
Isadora de Lourdes Signorini Souza
AAAmanda Caroline Camillo Andrade
Amanda Caroline Camillo Andrade
LSLeonardo Souza
Leonardo Souza
FPFabio Passetti
Fabio Passetti
Alzheimer’s Disease (AD) is an age-related neurodegenerative disorder characterized by progressive memory loss and cognitive impairment, affecting 35 million individuals worldwide. Intracerebroventricular (ICV) injection of low to moderate doses of streptozotocin (STZ) in adult male Wistar rats can reproduce classical physiopathological hallmarks of AD. This biological model is known as ICV-STZ. Most studies are focused on the description of behavioral and morphological aspects of the ICV-STZ model. However, knowledge regarding the molecular aspects of the ICV-STZ model is still incipient. Therefore, this work is a first attempt to provide a wide proteome description of the ICV-STZ model based on mass spectrometry (MS). To achieve that, samples from the pre-frontal cortex (PFC) and hippocampus (HPC) of the ICV-STZ model and control (wild-type) were used. Differential protein abundance, pathway, and network analysis were performed based on the protein identification and quantification of the samples. Our analysis revealed dysregulated biological pathways implicated in the early stages of late-onset Alzheimer’s disease (LOAD), based on differentially abundant proteins (DAPs). Some of these DAPs had their mRNA expression further investigated through qRT-PCR. Our results shed light on the AD onset and demonstrate the ICV-STZ as a valid model for LOAD proteome description.

1 January 2018 in Journal of Proteomics
Verified
Journal Article
Closed access
HWHelisa Helena Wippel
Helisa Helena Wippel
MSMarlon Dias Mariano Santos
Marlon Dias Mariano Santos
MCMilan Avila Clasen
Milan Avila Clasen
LKLouise Ulrich Kurt
Louise Ulrich Kurt
FNFábio Nogueira
Fábio Nogueira
JCJuliana de Saldanha da Gama Fischer Carvalho
Juliana de Saldanha da Gama Fischer Carvalho

25 June 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JSJanaína M. Silva
Janaína M. Silva
HWHelisa H. Wippel
Helisa H. Wippel
MSMarlon D. M. Santos
Marlon D. M. Santos
DVDenildo C. A. Verissimo
Denildo C. A. Verissimo
RSRenata M. Santos
Renata M. Santos
JCJuliana de Saldanha da Gama Fischer Carvalho
Juliana de Saldanha da Gama Fischer Carvalho
Meningiomas are among the most common primary tumors of the central nervous system (CNS) and originate from the arachnoid or meningothelial cells of the meninges. Surgery is the first option of treatment, but depending on the location and invasion patterns, complete removal of the tumor is not always feasible. Reports indicate many differences in meningiomas from male versus female patients; for example, incidence is higher in females, whereas males usually develop the malignant and more aggressive type. With this as motivation, we used shotgun proteomics to compare the proteomic profile of grade I meningioma biopsies of male and female patients. Our results listed several differentially abundant proteins between the two groups; some examples are S100-A4 and proteins involved in RNA splicing events. For males, we identified enriched pathways for cell-matrix organization and for females, pathways related to RNA transporting and processing. We believe our findings contribute to the understanding of the molecular differences between grade I meningiomas of female and male patients.

16 December 2021 in Stem Cells International
Verified
Journal Article
Open access
PDF file
BBBernardo Bonilauri
Bernardo Bonilauri
ACAmanda C. Camillo-Andrade
Amanda C. Camillo-Andrade
MSMarlon Dias Mariano dos Santos
Marlon Dias Mariano dos Santos
JCJuliana de Saldanha da Gama Fischer Carvalho
Juliana de Saldanha da Gama Fischer Carvalho
PCPaulo Carvalho
Paulo Carvalho
BDBruno Dallagiovanna
Bruno Dallagiovanna
Background. Obesity is characterized as a disease that directly affects the whole-body metabolism and is associated with excess fat mass and several related comorbidities. Dynamics of adipocyte hypertrophy and hyperplasia play an important role in health and disease, especially in obesity. Human adipose-derived stem cells (hASC) represent an important source for understanding the entire adipogenic differentiation process. However, little is known about the triggering step of adipogenesis in hASC. Here, we performed a proteogenomic approach for understanding the protein abundance alterations during the initiation of the adipogenic differentiation process. Methods. hASC were isolated from adipose tissue of three donors and were then characterized and expanded. Cells were cultured for 24 hours in adipogenic differentiation medium followed by protein extraction. We used shotgun proteomics to compare the proteomic profile of 24h-adipogenic, differentiated, and undifferentiated hASC. We also used our previous next-generation sequencing data (RNA-seq) of the total and polysomal mRNA fractions of hASC to study posttranscriptional regulation during the initial steps of adipogenesis. Results. We identified 3420 proteins out of 48,336 peptides, of which 92 proteins were exclusively identified in undifferentiated hASC and 53 proteins were exclusively found in 24h-differentiated cells. Using a stringent criterion, we identified 33 differentially abundant proteins when comparing 24h-differentiated and undifferentiated hASC (14 upregulated and 19 downregulated, respectively). Among the upregulated proteins, we shortlisted several adipogenesis-related proteins. A combined analysis of the proteome and the transcriptome allowed the identification of positive correlation coefficients between proteins and mRNAs. Conclusions. These results demonstrate a specific proteome profile related to adipogenesis at the beginning (24 hours) of the differentiation process in hASC, which advances the understanding of human adipogenesis and obesity. Adipogenic differentiation is finely regulated at the transcriptional, posttranscriptional, and posttranslational levels.